# Xilio Therapeutics (stock symbol: XLO) Logo in transparent PNG and SVG formats

## Xilio Therapeutics Logo large

### Xilio Therapeutics Logo large Download PNG (61.38 KB)

![Xilio Therapeutics Logo large Download PNG (61.38 KB)](/img/orig/XLO_BIG-d78b92b7.png)

### Xilio Therapeutics Logo large Download SVG (7.52 KB)

![Xilio Therapeutics Logo large Download SVG (7.52 KB)](/img/orig/XLO_BIG-73992d0e.svg)

## Xilio Therapeutics Logo icon format

### Xilio Therapeutics Logo icon format Download PNG (46.69 KB)

![Xilio Therapeutics Logo icon format Download PNG (46.69 KB)](/img/orig/XLO-a94c5dd1.png)

### Xilio Therapeutics Logo icon format Download SVG (2.73 KB)

![Xilio Therapeutics Logo icon format Download SVG (2.73 KB)](/img/orig/XLO-964d39d0.svg)

## Xilio Therapeutics Logo large for dark backgrounds

### Xilio Therapeutics Logo large for dark backgrounds Download PNG (62.54 KB)

![Xilio Therapeutics Logo large for dark backgrounds Download PNG (62.54 KB)](/img/orig/XLO_BIG.D-6edaaa37.png)

### Xilio Therapeutics Logo large for dark backgrounds Download SVG (6.79 KB)

![Xilio Therapeutics Logo large for dark backgrounds Download SVG (6.79 KB)](/img/orig/XLO_BIG.D-a94c61bc.svg)

## Xilio Therapeutics Logo icon format for dark backgrounds

### Xilio Therapeutics Logo icon format for dark backgrounds Download PNG (46.43 KB)

![Xilio Therapeutics Logo icon format for dark backgrounds Download PNG (46.43 KB)](/img/orig/XLO.D-3611b904.png)

### Xilio Therapeutics Logo icon format for dark backgrounds Download SVG (2.73 KB)

![Xilio Therapeutics Logo icon format for dark backgrounds Download SVG (2.73 KB)](/img/orig/XLO.D-e8dfaacb.svg)

## About Xilio Therapeutics

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, an IL-15 product candidate that are masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts.

1. Website domain: xiliotx.com
2. Employees: 74
3. Marketcap: $90.65 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
